Clinical trial
Ulipristal Acetate Versus GnRH Analogue for Myometrial Preservation in Patients With Submucosal Uterine Leiomyoma G2
NCT02357563 is registered in ClinicalTrials.gov with University Magna Graecia as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Ulipristal Acetate Versus GnRH Analogue for Myometrial Preservation in Patients With Submucosal Uterine Leiomyoma G2
- Lead sponsor
- University Magna Graecia
- Phase
- Phase 4
- Overall status
- Unknown status
- Start date
- February 28, 2015
- Completion date
- September 30, 2017
- Enrollment
- 110 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
fibroid